CJC-1295 DAC
CJC-1295 DAC is a synthetic GHRH-analog peptide conjugated to a drug-affinity complex (DAC) that binds serum albumin, extending plasma stability from minutes to days. It is a sustained-release reference compound in somatotropic-axis signaling research.
A sustained-release GHRH-analog reference compound for pituitary-axis studies.
What it is
CJC-1295 with DAC is a modified GHRH(1-29) analog bearing a maleimidopropionic-acid drug-affinity complex that forms a covalent bond with circulating albumin, markedly extending its plasma residence.
As a tool compound it is studied in vitro and in pre-clinical models of GHRH-receptor signaling and sustained-release pharmacokinetics. Supplied for laboratory research only.
Reconstitution & storage
- Reconstitute with bacteriostatic water — add slowly down the vial wall and swirl gently; do not shake.
- Store lyophilized vials at -20°C; once reconstituted keep at 2–8°C and use within ~4 weeks.
- Protect from light and avoid repeated freeze–thaw cycles.
Cited research applications
Questions
For Research Use Only. Not for human or animal consumption. This product has not been evaluated by the Food and Drug Administration. Not intended to diagnose, treat, cure, or prevent any disease. CJC-1295 DAC is sold strictly as a research chemical for in-vitro and pre-clinical laboratory investigation only.